Biotech Showcase
January 11–13, 2027 | San Francisco, CA
January 19–20, 2027 | Digital Partnering

PRESENT AT BIOTECH SHOWCASE

Presenting allows you to raise your profile with potential investors and strategic partners, and includes one-to-one meetings and informal networking

What’s new at Biotech Showcase?

Therapeutic area presentation streams

Presenting companies will be organized into 18 therapeutic area streams, each with a dedicated day and time block. This focused format brings companies with similar areas of interest together, making it easier for investors to discover relevant opportunities, plan their schedules and stay engaged across multiple presentations.

Analyst overviews of therapeutic and technology areas

Each therapeutic and technology stream will open with a 15-minute analyst-led market overview, followed by Q&A and introductions to the presenting companies. These expert insights provide investors with valuable market context while giving presenting companies additional exposure to engaged, targeted audiences.

Media alley

Media Alley is a new hub for media and content creation at Biotech Showcase, designed to amplify the visibility of presenting companies. The space will offer opportunities for press release distribution, on-site interviews and potential live podcast recordings, helping companies generate valuable exposure and extend their presence beyond the event.

New 18 Therapeutic streams

Presenting companies will be organized into 18 therapeutic and technology streams informed by areas of investor interest, helping investors and potential partners find companies relevant to the sectors they follow.

expand_more

Click to see the full list:

1. Oncology & Immuno-Oncology
The most consistently sought-after therapeutic category in biotech investing, and the anchor category for Biotech Showcase's investor base. Oncology-focused companies step into a room already primed for deal-making.

2. AI, Data Science & Advanced Computing
The fastest-moving story in the room. Investor appetite here rivals the largest disease categories, reflecting how central AI and computational tools have become to every stage of drug development.

3. Drug Discovery, Manufacturing & Contract Services (CDMO/CRO)
The connective tissue of the entire industry — the platforms, manufacturing partners, and service providers every other category on this list depends on. One of the deepest pools of investor engagement at the show.

4. DigiMed: MedTech, Medical Device & Digital Medicine
Home to Biotech Showcase's dedicated MedTech, device, and digital-medicine track — one of the largest and fastest-growing pools of capital in healthcare investing today, spanning surgical devices, diagnostic hardware, and AI-enabled digital health platforms. A distinct, well-capitalized investor base with its own dedicated showcase track and its own dedicated appetite for what's next.

5. Immunology, Inflammation & Dermatology
A powerhouse category spanning autoimmune, inflammatory, and immune-mediated disease — one of the deepest and most active areas of investor conversation at the show.

6. Neuroscience & Brain Health
From neurodegenerative disease to psychiatric, pain, and neurological indications, this category commands sustained, high-volume investor attention year after year.

7. Cell & Gene Therapy, Hematology & Transplant Medicine
Home to some of biotech's most technically ambitious science — CAR-T, gene editing, and regenerative medicine draw an investor base that skews sophisticated and deeply engaged.

8. Diagnostics & Personalized Medicine
A rapidly maturing category with a highly engaged investor base tracking the shift toward precision-guided care.

9. Cardiometabolic & Renal Health
Cardiovascular, metabolic, and renal programs sit at the center of one of the fastest-growing investment theses in biopharma, drawing a dedicated and well-capitalized audience.

10. Women's Health, Reproductive & Urologic Medicine
Among the fastest-rising categories in life sciences investing, with a passionate, high-engagement investor community actively seeking new entrants.

11. Rare & Orphan Disease
A category defined by depth over breadth — a smaller, highly specialized set of investors with outsized conviction and a track record of fast-moving deals.

12. Next-Gen Biologics, Radiopharmaceuticals & Drug Delivery
A focused, technically sophisticated investor audience following novel-modality science closely — an increasingly hot corner of dealmaking industry-wide.

13. Musculoskeletal & Ophthalmic Therapeutics
A focused specialty audience of investors who track these organ-specific spaces closely, offering presenting companies a rare chance to stand out in a less-crowded room.

14. Hepatic, GI & Metabolic Liver Disease
A steadily growing area of investor interest, anchored by a knowledgeable audience following developments in liver and GI disease closely.

15. Infectious Disease & Vaccines
A compact, mission-driven investor community that moves decisively when the science is compelling.

16. Genomics, Multi-Omics & Sequencing
A specialized, technically fluent investor niche with deep expertise across sequencing, proteomics, and multi-omics platforms.

17. Longevity & Healthspan
One of the fastest-growing, most closely watched niches in biotech investing today — a strong candidate for its own dedicated investor tracking in 2027.

18. The Next Wave of Therapeutics: Innovation Across the Biopharma Ecosystem

This is a general area for companies that don’t fit into one of the other areas or cannot present at the specific date/time of their bucket area.

Why Present at Biotech Showcase?

Access the right audience

  • Connect with investors managing over $400 billion in capital
  • Presenting companies receive 20% more one-on-one meetings than non-presenters


Enhanced visibility & support

  • 30-minute presentation slot for public companies, 15 minute presentation slots for private companies, plus full event registration
  • Promotional marketing across all channels leading up to the event
  • Press release distribution and ready-to-use templates [View press release templates here]
  • Comprehensive presenter guidelines and support

Priority review deadlines

Apply early and receive priority review and presentation slot placements.

Round 1 | July 31, 2026
Round 2 | August 14, 2026
Round 3 | August 28, 2026
Round 4 | September 11, 2026

Round 5 | September 25, 2026
Round 6 | October 9, 2026
Round 7 | October 23, 2026
Round 8 | November 6, 2026


Round 9 | November 20, 2026
Round 10 | December 4, 2026
Round 11 | December 18, 2026
Round 12 | January 1, 2027

Presentation Options and Fees

PLEASE NOTE: Company presenters need to apply first before registering for Biotech Showcase. Once approved, presenters will be sent special instructions to complete their registration.

Click here for information on the cancellation policy, payments, and sending a replacement.

Private and Public Company Presentation

Private and public life science companies are invited to request a 15-minute corporate presentation slot. This includes venture and angel-backed private companies, as well as mid-, small-, and micro-cap public companies.

Fee Structure

All-Access Presentation

  • $5,515 - before October 2, 2026
  • $5,715 - before November 13, 2026
  • $5,915 - after November 14, 2026
  • $6,015 - after January 11, 2027

Includes:

  • A 15-minute in-person presentation in San Francisco
  • Ability to request meetings with investors and other attendees using the partneringONE software

Qualified Company Categories

Presentation slots are open to all therapeutic categories including:

  • Small/large molecule R&D therapeutics
  • Platform
  • Digital Therapeutic and Medtech Companies
  • Tool/Device companies
  • Drug Delivery
  • Molecular Diagnostic and Personalized Medicine
  • Research Focused Service Providers
  • AI and Machine Learning

Questions?

Send all of your presenting company questions to our team at PresenterInfo@demy-colton.com